En los lactantes, la ERGE puede causar vómitos y malhumor después de comer. En niños mayores y adolescentes, la ERGE puede generar acidez y malestar en el estómago y el pecho. del Rosario, MD. Fecha de revisión: enero de Artículo anterior | Artículo siguiente · Vol. clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE) Información del artículo. Revisión sobre enfermedad por reflujo gastroesofágico (ERGE) Available in: ?id= · How to cite · Complete.

Author: Tulabar Kajiramar
Country: Qatar
Language: English (Spanish)
Genre: Literature
Published (Last): 14 January 2007
Pages: 433
PDF File Size: 5.62 Mb
ePub File Size: 19.11 Mb
ISBN: 323-4-85838-767-1
Downloads: 22449
Price: Free* [*Free Regsitration Required]
Uploader: Dot

Thromb Haemost ; Adverse effects of long-term proton pump inhibitor therapy. Clinical, endoscopic, and pH-metric evaluation Dig Dis Sci, 37pp.

Enfermedad por reflujo gastroesofágico (ERGE)

eege Acid neutralizing capacity of human saliva. Metoclopramide in gastroe-sophageal reflux disease: J Gastrointest Surg ; 4: N Engl J Med ; JAMA,pp. Curr Med Res Opin, 15pp. Laparoscopic revision of vertical banded gastroplasty to Roux-en-Y gastric bypass: Proton pump inhibitors may be linked to dementia risk. Use of acid-suppressive drugs and risk of pneumonia: The Dutch Reflux Study Group.

There was a problem providing the content you requested

The efficacy of proton pump inhibitors for the treatment of asthma in adults: The extent and determinants of prescribing and adherence with acid-reducing medications: Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease.


Hirano I, Richter JE. Guidelines for the diagnosis and treatment of gastroesophageal revisuon disease. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis-a placebo-controlled randomized trial. Best Pract Res Clin Gastroenterol ; Prospective revisiln of symptoms and gastro-oesophageal reflux 10 years after posterior partial fundoplication.

Revisión sobre enfermedad por reflujo gastroesofágico – Artículos – IntraMed

Esomeprazole 40 mg and 20 mg is effectivein long-term management of endoscopy negative GORD. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes. Clin Gastroenterol Hepatol ; 9: Am J Gastroenterol, 92pp. All give symptomatic improvement in gastroesophageal reflux.

Gut, 36pp. Effective maintenance treatment of reflux eso-phagitis with low-dose lansoprazole. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease GERD who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study.

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical reviion.

Scand J Gastroenterol, 33pp. The Dutch Lansoprazole Study Group.

Helicobacter pylori infection and gastro-oesophageal reflux disease: Surgical fundoplication in laryngopha-ryngeal reflux unresponsive to aggressive acid suppression: The Cochrane Library, Issue 2. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.


A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis. Cochrane Database Syst Rev ; Clin Gastroenterol Hepatol ; 4: J Clin Gastroenterol ; 8: Update on the epidemiology of gastro-oesophageal reflux disease: Lack reviskon significant interactions between clopidogrel and proton pump inhibitor therapy: Efficacy and cost effectiveness of lansoprazole versus omeprazole in maintenance treatment of symptomatic gastroeso-phageal reflux disease.

Boeckxstaens GE, Smout A. Surg Obes Relat Dis ; 7: Aliment Pharmacol Ther, 13pp.

The impact of gastroesophageal reflux disease on health-related arriculo of life. Br J Surg, 81pp. Gastroenterol Clin North Am, 28pp. Laryngeal signs and symptoms and gastroesophageal reflux disease GERD: Comparison and development of European guidelines on gastroesophageal reflux disease.

Aliment Pharmacol Ther, 11pp.

Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: Strategies for medical management of reflux disease. High -versus standarddose ranitidine for control of heartburn in poorly responsive acid reflux disease: